Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
17 February, 2019 11:54 IST
Suven Life Sciences secures 2 overseas product patents
Source: IRIS | 06 Nov, 2018, 10.54AM
Comments  |  Post Comment

Suven Life Sciences announces today that the grant of one product patent from Israel and one product patent from Japan corresponding to the New Chemical Entities for the treatment of disorders associated with Neurodegenerative diseases and patents are valid through 2036 and 2034 respectively.

The granted claims of the patents include the class of selective M1 PAM and 5-HT4 compounds respectively and are being developed as therapeutic agents for neurodegenerative disorders such as for the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer's disease, Attention deficient hyperactivity disorder (ADHD), Huntington's disease, Parkinson and Schizophrenia etc.

''We are very pleased by the grant of these patents to Suven for our pipeline of molecules in CNS arena that are being developed for cognitive disorders with high unmet medical need with huge market potential globally,'' said Venkat Jasti, CEO of Suven.

Shares of the company gained Rs 3.25, or 1.35%, to trade at Rs 244.00. The total volume of shares traded was 15,444 at the BSE (10.42 a.m., Tuesday).



Suven Life Sciences Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Lupin launches Clobazam oral suspension - 15-Feb-2019 16:37
Zydus gets USFDA nod for Triamterene & Hydrochlorothiazide capsules - 13-Feb-2019 13:10
L&T Construction bags contract for construction of hospitals - 13-Feb-2019 11:56
Strides receives USFDA approval for Triamcinolone Acetonide cream - 13-Feb-2019 11:52
Lupin receives FDA approval for Fluoxetine Tablets - 12-Feb-2019 16:32
Lupin launches Tadalafil Tablets - 12-Feb-2019 16:29
C & C Constructions JV wins order worth Rs 1.24 bn from DFCCIL - 12-Feb-2019 13:44
Tata Motors group global wholesales up 12% in January 2019 - 12-Feb-2019 13:39
Alembic Pharma announces completion of USFDA inspection at Aleor Dermaceuticals - 12-Feb-2019 10:37
L&T Hydrocarbon Engineering bags order from Sonatrach-Algeria - 12-Feb-2019 10:32
Aurobindo Pharma completes acquisition of businesses in 5 European countries - 11-Feb-2019 11:05
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer